(Q77713974)

English

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer

scientific article published on 01 November 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

E Van Cutsem

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

H Starkhammar

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

L Dirix

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E Terzoli

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F Cognetti

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Y Humblet

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Garufi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

L Filez

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Gruia

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Cote

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Barone

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 November 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1199-1204

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of irinotecan in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008478405634

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008478405634

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862050%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77713974&oldid=1758001897"